Drug Trial Radar · NCT03068754
Study of Acthar® Gel (Acthar) for Amyotrophic Lateral Sclerosis (ALS)
Last checked: Nov 20, 2026Latest source record: Oct 14, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
143
Actual
Start
Jun 22, 2017
Primary completion
Nov 25, 2019
Study completion Nov 25, 2019
Sponsor
- Lead sponsor
- MallinckrodtIndustry
- Sponsor type
- Industry
- First posted
- Mar 3, 2017
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
About 213 people with ALS will participate in this study. There will be locations in North and South America. During the first part, participants will be randomly assigned to a group (like by flipping a coin). Out of every 3: * 2 will get the study drug * 1 will get a look-alike with no drug in it (placebo) During the second part, everyone will get the study drug. Participation will help doctors find out if Acthar can help or slow down the symptoms of ALS better than placebo.
Conditions
- Amyotrophic Lateral Sclerosis
Interventions
ActharDrug
Repository corticotropin for subcutaneous injection
PlaceboDrug
Matching placebo for subcutaneous injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Treatment Period: Scores on a Scale for Telephone-administered Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-R)Time frame: Baseline, Week 36
- Number of Participants Experiencing an Adverse Event During the Treatment PeriodTime frame: by the end of the treatment period (within 36 Weeks)
- Number of Participants Experiencing an Adverse Event by the End of the Trial in the OLE PeriodTime frame: by the time of database lock (within 84 weeks)
Locations
69 sites in 7 countries. Site status is shown where the registry gives one.
Neuromuscular Research Center
Phoenix, Arizona
Mayo Clinic - Arizona
Scottsdale, Arizona
University of California San Diego
La Jolla, California
Loma Linda University Health System, Department of Neurology
Loma Linda, California
Keck School of Medicine, University of Southern California
Los Angeles, California
University of California Los Angeles
Los Angeles, California
University of California Irvine Medical Center
Orange, California
California Pacific Medical Center
San Francisco, California
University of California San Francisco
San Francisco, California
Colorado Springs Neurological Associates
Colorado Springs, Colorado
Georgetown University
Washington D.C., District of Columbia
George Washington University
Washington D.C., District of Columbia
University of Florida - McKnight Brain Institute
Gainesville, Florida
University of South Florida
Tampa, Florida
Emory University
Atlanta, Georgia
Augusta University
Augusta, Georgia
Indiana University-Neuroscience Center of Excellence/Goodman Hall
Indianapolis, Indiana
University of Kansas Medical Center
Kansas City, Kansas
University of Kentucky Chandler Medical Center
Lexington, Kentucky
John Hopkins Outpatient Center
Baltimore, Maryland
University of Massachusetts Medical School
Worcester, Massachusetts
Mercy Health- Saint Mary's
Grand Rapids, Michigan
Neurology Associates
Lincoln, Nebraska
University of Nebraska Medical Center - Physicians Clinical Neurosciences Center
Omaha, Nebraska
Las Vegas Clinic
Las Vegas, Nevada
Jersey Shore University Medical Center
Neptune City, New Jersey
Columbia Presbyterian Hospital
New York, New York
Providence ALS Center
Portland, Oregon
Penn State Health Milton S. Hershey Medical Center
Hershey, Pennsylvania
Temple University School of Medicine
Philadelphia, Pennsylvania
Allegheny General Hospital
Pittsburgh, Pennsylvania
Wesley Neurology Clinic
Cordova, Tennessee
Austin Neuromuscular Center
Austin, Texas
Texas Neurology, P.A.
Dallas, Texas
The Methodist Hospital
Houston, Texas
University of Vermont Medical Center
Colchester, Vermont
VCU Medical Center
Richmond, Virginia
Swedish Neuroscience Institute
Seattle, Washington
Medical College of Wisconsin/Froedtert Hospital
Milwaukee, Wisconsin
IADIN
Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
Showing 40 of 69 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.